UnitedHealth Group Incorporated (NYSE:UNH)
UnitedHealth Group Incorporated (NYSE:UNH) represented a move of -3.22 percent or $7.69 per share and closed its previous day trading session at $256.32. 5.27 Million Shares were traded in the last trading session with an Average Volume of 2.69 Million Shares. The stock currently has a Market Capitalization of 248.1 Billion.
UnitedHealthcare Group Inc. is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with the physicians and care professionals, and hospitals and other care facilities nationwide.
The stock traded between $207.07 and $272.81 over 1-Year time period showing its price to sales ratio of 1.13. UnitedHealth Group Incorporated (NYSE:UNH) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-3.39 and 200-Day Simple Moving Average of $4.43. Its Price to Free Cash Flow is 23.37 and Price to Book of 5.1.
Analyst’s recommended the stock as 1.6 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, UnitedHealth Group Incorporated (NYSE:UNH) reported its Actual EPS of $3.41/share. The analysts offering Earnings Estimates for the company were believing that UnitedHealth Group Incorporated could bring EPS of $3.29/share. The difference between Actual EPS and Estimated EPS was 0.12 Percent. Thus showing an Earnings Surprise of 3.6 Percent.
Endo International plc (NASDAQ:ENDP)
In the last trading session, Endo International plc (NASDAQ:ENDP) added its value by -9.71% closing at the price of $16.37. The stock currently has market capitalization of 3.67 Billion, with average volume of 4.66 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Endo International plc (NASDAQ:ENDP) is showing beta of 0.63. This particular value of beta suggests that Endo International plc (NASDAQ:ENDP) has historically moved 63% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Endo International plc (NASDAQ:ENDP) is at $-4.29.
The stock currently has RSI of 43.67. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women’s health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Endo International plc (NASDAQ:ENDP) topped its 52-week high price of $18.50 on 10/17/18 and 52-Week Low Price of $ 5.27 on 04/04/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.78% and monthly volatility of 4.96% respectively.